论文部分内容阅读
对４８０例经１３１Ⅰ治疗的甲亢患者的疗效与是否伴突眼以及突眼症状是否有改善等系列问题进行了分析研究。结果表明：４８０例甲亢患者中２３３例伴突眼，其发病率为４９％，２３３例突眼患者中，９０例突眼恢复（３９％），好转９６例（４１％）．未变化４５例（１９％），加重２例（０．８５％），总有效率８０％。认为甲亢的治疗效果与有无伴发突眼关系不密切，１３１Ⅰ治疗甲亢伴突眼者可使大部分突眼症状得到明显改善。据此，我们认为在甲亢伴突眼的治疗中１３１Ⅰ应视为一种有效和较好的治疗方法。
The curative effect of 480 patients with hyperthyroidism treated by 131 Ⅰ and whether with or without exophthalmos and the improvement of exophthalmos symptoms were analyzed. The results showed that 233 of 480 cases with hyperthyroidism were accompanied with exophthalmos and the incidence was 49%. Out of 233 patients with exophthalmos, 90 cases recovered (39%) and 96 cases (41%) recovered. No change in 45 cases (19%), exacerbations in 2 cases (0.85%), the total efficiency of 80%. That the treatment of hyperthyroidism with or without associated exophthalmos is not closely related, 131I treatment of hyperthyroidism with exophthalmos can make most of the symptoms of the eye has been significantly improved. Accordingly, we believe 131I should be considered as an effective and better treatment in hyperthyroidism with exophthalmos.